(Q35888438)

English

Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy

scientific article published on 10 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

A Pohl

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

A El-Khoueiry

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

D Yang

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

W Zhang

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

G Lurje

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Y Ning

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

T Winder

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

S Hu-Lieskoven

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

S Iqbal

9

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

K D Danenberg

10

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

M Kahn

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

J-L Teo

12

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

J Shriki

13

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

J Stebbing

14

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

H-J Lenz

15

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

10 January 2012

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

13

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

173-180

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

https://scigraph.springernature.com/pub.10.1038/tpj.2011.61

0 references

Glioblastoma stem-like cells give rise to tumour endothelium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Targeting CD133 antigen in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Stem cells in colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Identification and expansion of human colon-cancer-initiating cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Prospective identification of tumorigenic prostate cancer stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Prediction error estimation: a comparison of resampling methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Prospective identification of tumorigenic breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

11 July 2018

CD133(+) human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

24 September 2018

Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

24 September 2018

CD133+CD44+ population efficiently enriches colon cancer initiating cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

24 September 2018

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326190

24 September 2018

A comparison of two simple hazard ratio estimators based on the logrank test

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro formation of capillary tubules from human umbilical cord blood cells with perspectives for therapeutic application

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/TPJ.2011.61

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35888438&oldid=1604614717"